AR241800A1 - Procedimiento para preparar compuestos de eglina y procedimiento para obtener preparados farmaceuticos que incluyan a dichos compuestos de eglina como agente activo. - Google Patents
Procedimiento para preparar compuestos de eglina y procedimiento para obtener preparados farmaceuticos que incluyan a dichos compuestos de eglina como agente activo.Info
- Publication number
- AR241800A1 AR241800A1 AR84298668A AR29866884A AR241800A1 AR 241800 A1 AR241800 A1 AR 241800A1 AR 84298668 A AR84298668 A AR 84298668A AR 29866884 A AR29866884 A AR 29866884A AR 241800 A1 AR241800 A1 AR 241800A1
- Authority
- AR
- Argentina
- Prior art keywords
- val
- phe
- compounds
- glu
- pro
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 108091026890 Coding region Proteins 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 101150012394 PHO5 gene Proteins 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000000050 nutritive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physics & Mathematics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PROCEDIMIENTO PARA ELABORAR COMPUESTOS DE EGLINA DE LA FORMULA: B-PRO-GLU- VAL-VAL-GLY-LYS-THR-VAL-ASP-GLN-ALA-ARG-GLU-TYR-PHE-THR-LEU-HIS-TYR-PRO-GLN TYR-ASP-VAL-W-PHE-LEU-PRO-GLU-GLY-SER-PRO-VAL-THR-LEU-ASP-LEU-ARG-TYR-ASN- ARG-VAL-ARG-VAL-PHE-TYR-ASN-PRO-GLY-THR-ASN-VAL-VAL-ASN-HIS-VAL-PRO-HIS-VAL GLY EN QUE B ES UN RADICAL PEPTIDICO SELECCIONADO DEL GRUPO FORMADO POR LEU LYS-SER-PHE-,SER-GLU-LEU-LYS-SER-PHE O THR-GLU-PHE-GLY-SER-GLU-LEY-LYS-SER- PHE, Y W ES TYR O HIS, EN FORMA LIBRE O ACETILADA, Y LAS SALES SE CULTIVAN CELULAS DE ESCHERICHIS COLI, TRANSFORMADAS CON UN PLASMIDOHIBRIDO QUE ES UNA SECUENCIA DNA CODIFICADORA PARA UNO DE LOS CITADOS COMPUESTOS DE EGLINA Y DE UN FRAGMENTO 4KBECORI-BAMHI DEL PLASMIDO PBR322, O CELULAS DE SACCHAROMICES CEREVISIAS TRANSFORMADSAS CON UN PLASMIDO HIBRIDO QUE ES UNA PRIMERA SECUENCIA DNA CONTENIENDO EL PROMOTOR PHO5, LA CUAL SE VINCULA CON UNA SEGUNDA SECUENCIA DNA CODIFICADORA PARA UNO DE LOS COMPUESTOS DE EGLINA A TRAVES DE UN LIGAMIENTO E CORI Y DEL FRAGMENTO 6,2 KB BAMHI-SAII DEL VECTOR DE LEVADURA PJDB207 ES UN MEDIO NUTRITIVO LIQUIDO CON V Y N, Y EL PRODUCTO SE LIBERA DE LAS CELULAS HOSPEDADORAS Y SE AISLAPOR CROMATOGRAFIA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH642283 | 1983-11-21 | ||
| CH186384 | 1984-04-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR241800A1 true AR241800A1 (es) | 1992-12-30 |
Family
ID=25688872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR84298668A AR241800A1 (es) | 1983-11-21 | 1984-11-20 | Procedimiento para preparar compuestos de eglina y procedimiento para obtener preparados farmaceuticos que incluyan a dichos compuestos de eglina como agente activo. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20020142414A1 (es) |
| EP (1) | EP0146785B1 (es) |
| JP (1) | JPH0730119B2 (es) |
| KR (1) | KR850004791A (es) |
| AR (1) | AR241800A1 (es) |
| CA (1) | CA1297437C (es) |
| DE (1) | DE3481320D1 (es) |
| DK (1) | DK550984A (es) |
| ES (1) | ES8608580A1 (es) |
| FI (1) | FI86744C (es) |
| GR (1) | GR80965B (es) |
| HU (1) | HU203784B (es) |
| IE (1) | IE57895B1 (es) |
| IL (1) | IL73569A (es) |
| NO (1) | NO172547C (es) |
| NZ (1) | NZ210267A (es) |
| PT (1) | PT79519B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61152695A (ja) * | 1984-12-26 | 1986-07-11 | Nippon Shinyaku Co Ltd | 長鎖ｄｎａの合成法 |
| JPS6339414U (es) * | 1986-08-29 | 1988-03-14 | ||
| EP0263072B1 (en) | 1986-10-03 | 1994-03-23 | Ciba-Geigy Ag | Novel lymphokine related peptides |
| US5180667A (en) * | 1988-03-07 | 1993-01-19 | Ciba-Geigy Corporation | Genes encoding eglin C mutants |
| EP0332576B1 (de) * | 1988-03-07 | 1994-04-06 | Ciba-Geigy Ag | Modifizierte Proteine |
| DE3939801A1 (de) * | 1989-12-01 | 1991-06-06 | Basf Ag | Neue proteine und ihre herstellung |
| US5604201A (en) * | 1993-01-08 | 1997-02-18 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization | Methods and reagents for inhibiting furin endoprotease |
| JP2013192526A (ja) * | 2012-03-22 | 2013-09-30 | Sanyo Chem Ind Ltd | タンパク質溶液、このタンパク質溶液のプロテアーゼ活性の回復方法及びこのタンパク質溶液を含有する洗剤組成物 |
| CN108456708A (zh) * | 2018-06-20 | 2018-08-28 | 齐齐哈尔龙江阜丰生物科技有限公司 | 一种发酵制备苏氨酸的培养基 |
| EP4225337A1 (en) * | 2020-10-06 | 2023-08-16 | Mayo Foundation for Medical Education and Research | Methods and materials for treating gastrointestinal disorders |
| US11187700B1 (en) * | 2021-01-28 | 2021-11-30 | Eckhard Kemmann | Closed system for enlarging viral and bacterial particles for identification by diffraction scanning |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2808396C2 (de) * | 1978-02-27 | 1984-04-19 | Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn | Protease-Inhibitoren |
-
1984
- 1984-11-19 PT PT79519A patent/PT79519B/pt not_active IP Right Cessation
- 1984-11-19 FI FI844545A patent/FI86744C/fi not_active IP Right Cessation
- 1984-11-19 CA CA000468119A patent/CA1297437C/en not_active Expired - Lifetime
- 1984-11-19 GR GR80965A patent/GR80965B/el unknown
- 1984-11-20 DK DK550984A patent/DK550984A/da not_active Application Discontinuation
- 1984-11-20 IE IE2966/84A patent/IE57895B1/en not_active IP Right Cessation
- 1984-11-20 JP JP24353084A patent/JPH0730119B2/ja not_active Expired - Lifetime
- 1984-11-20 EP EP84114022A patent/EP0146785B1/de not_active Expired - Lifetime
- 1984-11-20 IL IL73569A patent/IL73569A/xx not_active IP Right Cessation
- 1984-11-20 NO NO844617A patent/NO172547C/no not_active IP Right Cessation
- 1984-11-20 DE DE8484114022T patent/DE3481320D1/de not_active Expired - Lifetime
- 1984-11-20 NZ NZ210267A patent/NZ210267A/xx unknown
- 1984-11-20 AR AR84298668A patent/AR241800A1/es active
- 1984-11-20 HU HU844308A patent/HU203784B/hu not_active IP Right Cessation
- 1984-11-21 KR KR1019840007283A patent/KR850004791A/ko not_active Application Discontinuation
- 1984-11-21 ES ES537829A patent/ES8608580A1/es not_active Expired
-
2001
- 2001-01-22 US US09/765,287 patent/US20020142414A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE3481320D1 (de) | 1990-03-15 |
| KR850004791A (ko) | 1985-07-27 |
| JPH0730119B2 (ja) | 1995-04-05 |
| EP0146785A1 (de) | 1985-07-03 |
| ES537829A0 (es) | 1986-06-16 |
| NO844617L (no) | 1985-05-22 |
| PT79519B (en) | 1986-12-11 |
| PT79519A (en) | 1984-12-01 |
| IE842966L (en) | 1985-05-21 |
| NZ210267A (en) | 1988-11-29 |
| FI844545L (fi) | 1985-05-22 |
| FI86744C (fi) | 1992-10-12 |
| NO172547C (no) | 1993-08-04 |
| FI86744B (fi) | 1992-06-30 |
| AU3571884A (en) | 1985-05-30 |
| IL73569A (en) | 1991-05-12 |
| US20020142414A1 (en) | 2002-10-03 |
| CA1297437C (en) | 1992-03-17 |
| DK550984D0 (da) | 1984-11-20 |
| JPS60192592A (ja) | 1985-10-01 |
| NO172547B (no) | 1993-04-26 |
| IE57895B1 (en) | 1993-05-05 |
| FI844545A0 (fi) | 1984-11-19 |
| DK550984A (da) | 1985-05-22 |
| HUT36864A (en) | 1985-10-28 |
| GR80965B (en) | 1985-03-20 |
| ES8608580A1 (es) | 1986-06-16 |
| AU596347B2 (en) | 1990-05-03 |
| HU203784B (en) | 1991-09-30 |
| EP0146785B1 (de) | 1990-02-07 |
| IL73569A0 (en) | 1985-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kominami et al. | Sequestration of cytoplasmic enzymes in an autophagic vacuole-lysosomal system induced by injection of leupeptin. | |
| Bisaccia et al. | Purification and reconstitution of two anion carriers from rat liver mitochondria: the dicarboxylate and the 2-oxoglutarate carrier | |
| AR241800A1 (es) | Procedimiento para preparar compuestos de eglina y procedimiento para obtener preparados farmaceuticos que incluyan a dichos compuestos de eglina como agente activo. | |
| Maire et al. | Neural structures involved in the genesis of ‘preoptic pulmonary edema,’gastric erosions and behavior changes | |
| GEP19981289B (en) | Method for Preparing Preserved Medicinal Means Containing Human Protein and Medicinal Means | |
| Zimmerman et al. | Multiple forms of Ca-activated protease from rat brain and muscle. | |
| EP0085250A3 (en) | Cationic oligopeptides having microbicidal activity | |
| SE8007763L (sv) | Sett att framstella en polypeptid | |
| CA2113995A1 (en) | Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins | |
| DE3484616D1 (de) | Enzymwiderstandsfaehige immunomodulatorische peptide. | |
| ES2178634T3 (es) | Peptidos analogos de cnp y su utilizacion. | |
| UA35636C2 (uk) | Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців | |
| MX9205985A (es) | Epitopes de las celulas t de los alergenos principales del genero dermatophagoides y composiciones farmaceuticas que los contienen. | |
| ES8200861A1 (es) | Procedimiento para la obtencion de acilpeptidos | |
| Hale et al. | Identification and partial purification of the cardiac sodium-calcium exchange protein. | |
| FI940375A0 (fi) | Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa | |
| SE8901041L (sv) | Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning | |
| ES2065946T3 (es) | Vector que contiene un promotor del gen de la beta-actina de pollo para la expresion de un gen deseado. | |
| HUP9802320A2 (hu) | Makrolidok, eljárás előállításukra és makrolidokat tartalmazó gyógyszerkészítmények | |
| KR840001836A (ko) | 생리활성 물질의 제법 | |
| ES2081817T3 (es) | Polipeptido con secuencias principales repetidas que se fijan en la celula. | |
| ATE10364T1 (de) | Retro-inverso analoga von c-terminalen pentaund hexapeptiden der verbindung p. | |
| Brock et al. | An amino acid transport system in Streptococcus faecium | |
| AR023481A1 (es) | Vectores que contienen un gen que codifica cd40 y/o cd40l bajo el control de un promotor citoquina-inducible, metodos para su produccion y usos de losmismos | |
| GB1271466A (en) | Thiocarbamic acid derivatives |